nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Hyperpyrexia—Penicillamine—rheumatoid arthritis	0.0469	0.171	CcSEcCtD
Droxidopa—Isoprenaline—ADRBK1—rheumatoid arthritis	0.0126	0.215	CrCbGaD
Droxidopa—Epinephrine—ADRBK1—rheumatoid arthritis	0.0106	0.18	CrCbGaD
Droxidopa—Aminosalicylic Acid—ALOX5—rheumatoid arthritis	0.00986	0.168	CrCbGaD
Droxidopa—Hypertension—Ergocalciferol—rheumatoid arthritis	0.00876	0.032	CcSEcCtD
Droxidopa—Blood pressure increased—Leflunomide—rheumatoid arthritis	0.00859	0.0314	CcSEcCtD
Droxidopa—Mesalazine—ALOX5—rheumatoid arthritis	0.00774	0.132	CrCbGaD
Droxidopa—Aminosalicylic Acid—MPO—rheumatoid arthritis	0.00636	0.108	CrCbGaD
Droxidopa—Mesalazine—MPO—rheumatoid arthritis	0.00499	0.0851	CrCbGaD
Droxidopa—Nausea—Ergocalciferol—rheumatoid arthritis	0.00492	0.018	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisolone—rheumatoid arthritis	0.00483	0.0176	CcSEcCtD
Droxidopa—Cardiac failure congestive—Hydrocortisone—rheumatoid arthritis	0.00472	0.0172	CcSEcCtD
Droxidopa—Urinary tract infection—Leflunomide—rheumatoid arthritis	0.00467	0.0171	CcSEcCtD
Droxidopa—Cardiac failure congestive—Triamcinolone—rheumatoid arthritis	0.00444	0.0162	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—rheumatoid arthritis	0.00443	0.0162	CcSEcCtD
Droxidopa—Arrhythmia—Azathioprine—rheumatoid arthritis	0.00408	0.0149	CcSEcCtD
Droxidopa—Cardiac failure congestive—Dexamethasone—rheumatoid arthritis	0.00403	0.0147	CcSEcCtD
Droxidopa—Cardiac failure congestive—Betamethasone—rheumatoid arthritis	0.00403	0.0147	CcSEcCtD
Droxidopa—Nausea—Auranofin—rheumatoid arthritis	0.00401	0.0146	CcSEcCtD
Droxidopa—Arrhythmia—Leflunomide—rheumatoid arthritis	0.00386	0.0141	CcSEcCtD
Droxidopa—Nausea—Penicillamine—rheumatoid arthritis	0.0037	0.0135	CcSEcCtD
Droxidopa—Urinary tract infection—Cyclosporine—rheumatoid arthritis	0.00361	0.0132	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—rheumatoid arthritis	0.00351	0.0128	CcSEcCtD
Droxidopa—Hypertension—Leflunomide—rheumatoid arthritis	0.00324	0.0118	CcSEcCtD
Droxidopa—Arrhythmia—Cyclosporine—rheumatoid arthritis	0.00298	0.0109	CcSEcCtD
Droxidopa—Arrhythmia—Prednisolone—rheumatoid arthritis	0.00271	0.00988	CcSEcCtD
Droxidopa—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.00268	0.00977	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—rheumatoid arthritis	0.00264	0.00965	CcSEcCtD
Droxidopa—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.00253	0.00922	CcSEcCtD
Droxidopa—Hypertension—Cyclosporine—rheumatoid arthritis	0.0025	0.00914	CcSEcCtD
Droxidopa—Arrhythmia—Triamcinolone—rheumatoid arthritis	0.00249	0.00909	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—rheumatoid arthritis	0.00248	0.00907	CcSEcCtD
Droxidopa—Confusional state—Cyclosporine—rheumatoid arthritis	0.00239	0.00871	CcSEcCtD
Droxidopa—Aminosalicylic Acid—PTGS2—rheumatoid arthritis	0.00238	0.0406	CrCbGaD
Droxidopa—Syncope—Prednisolone—rheumatoid arthritis	0.00237	0.00864	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.00232	0.00846	CcSEcCtD
Droxidopa—Syncope—Hydrocortisone—rheumatoid arthritis	0.00231	0.00843	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—rheumatoid arthritis	0.00228	0.00831	CcSEcCtD
Droxidopa—Epinephrine—TNF—rheumatoid arthritis	0.00227	0.0387	CrCbGaD
Droxidopa—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.00226	0.00827	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—rheumatoid arthritis	0.00226	0.00825	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—rheumatoid arthritis	0.00226	0.00825	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—rheumatoid arthritis	0.00222	0.00812	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—rheumatoid arthritis	0.00218	0.00794	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—rheumatoid arthritis	0.00217	0.00792	CcSEcCtD
Droxidopa—Dizziness—Azathioprine—rheumatoid arthritis	0.00215	0.00784	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.00213	0.00778	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.00213	0.00777	CcSEcCtD
Droxidopa—Shock—Prednisolone—rheumatoid arthritis	0.00212	0.00773	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—rheumatoid arthritis	0.00209	0.00765	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—rheumatoid arthritis	0.00209	0.00763	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—rheumatoid arthritis	0.00207	0.00755	CcSEcCtD
Droxidopa—Headache—Azathioprine—rheumatoid arthritis	0.00203	0.00742	CcSEcCtD
Droxidopa—Dizziness—Leflunomide—rheumatoid arthritis	0.00203	0.0074	CcSEcCtD
Droxidopa—Confusional state—Methylprednisolone—rheumatoid arthritis	0.00199	0.00727	CcSEcCtD
Droxidopa—Syncope—Betamethasone—rheumatoid arthritis	0.00197	0.00721	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—rheumatoid arthritis	0.00197	0.00721	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—rheumatoid arthritis	0.00197	0.00718	CcSEcCtD
Droxidopa—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.00195	0.00712	CcSEcCtD
Droxidopa—Shock—Triamcinolone—rheumatoid arthritis	0.00195	0.00711	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—rheumatoid arthritis	0.00194	0.0071	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.00193	0.00706	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.00193	0.00706	CcSEcCtD
Droxidopa—Nausea—Azathioprine—rheumatoid arthritis	0.00193	0.00704	CcSEcCtD
Droxidopa—Headache—Leflunomide—rheumatoid arthritis	0.00192	0.00701	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—rheumatoid arthritis	0.0019	0.00694	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—rheumatoid arthritis	0.0019	0.00694	CcSEcCtD
Droxidopa—Mesalazine—PTGS2—rheumatoid arthritis	0.00187	0.0319	CrCbGaD
Droxidopa—Nausea—Leflunomide—rheumatoid arthritis	0.00182	0.00665	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.00177	0.00648	CcSEcCtD
Droxidopa—Shock—Dexamethasone—rheumatoid arthritis	0.00177	0.00645	CcSEcCtD
Droxidopa—Shock—Betamethasone—rheumatoid arthritis	0.00177	0.00645	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.00173	0.00633	CcSEcCtD
Droxidopa—Syncope—Prednisone—rheumatoid arthritis	0.00172	0.00628	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—rheumatoid arthritis	0.00169	0.00615	CcSEcCtD
Droxidopa—Hypertension—Prednisone—rheumatoid arthritis	0.00166	0.00604	CcSEcCtD
Droxidopa—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.00163	0.00596	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00163	0.00594	CcSEcCtD
Droxidopa—Dizziness—Cyclosporine—rheumatoid arthritis	0.00156	0.00571	CcSEcCtD
Droxidopa—Shock—Prednisone—rheumatoid arthritis	0.00154	0.00562	CcSEcCtD
Droxidopa—Headache—Cyclosporine—rheumatoid arthritis	0.00148	0.00541	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.00148	0.0054	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.00148	0.0054	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—rheumatoid arthritis	0.00142	0.0052	CcSEcCtD
Droxidopa—Nausea—Cyclosporine—rheumatoid arthritis	0.00141	0.00513	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00139	0.00508	CcSEcCtD
Droxidopa—Headache—Prednisolone—rheumatoid arthritis	0.00135	0.00492	CcSEcCtD
Droxidopa—Confusional state—Methotrexate—rheumatoid arthritis	0.00132	0.00481	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—rheumatoid arthritis	0.00132	0.00481	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—rheumatoid arthritis	0.00131	0.00478	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00131	0.00477	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—rheumatoid arthritis	0.00129	0.00471	CcSEcCtD
Droxidopa—Nausea—Prednisolone—rheumatoid arthritis	0.00128	0.00467	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—rheumatoid arthritis	0.00125	0.00456	CcSEcCtD
Droxidopa—Headache—Triamcinolone—rheumatoid arthritis	0.00124	0.00453	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—rheumatoid arthritis	0.00124	0.00452	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—rheumatoid arthritis	0.00119	0.00434	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—rheumatoid arthritis	0.00119	0.00434	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—rheumatoid arthritis	0.00118	0.00429	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—rheumatoid arthritis	0.00117	0.00428	CcSEcCtD
Droxidopa—Headache—Dexamethasone—rheumatoid arthritis	0.00113	0.00411	CcSEcCtD
Droxidopa—Headache—Betamethasone—rheumatoid arthritis	0.00113	0.00411	CcSEcCtD
Droxidopa—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.00108	0.00393	CcSEcCtD
Droxidopa—Nausea—Betamethasone—rheumatoid arthritis	0.00107	0.0039	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—rheumatoid arthritis	0.00107	0.0039	CcSEcCtD
Droxidopa—Dizziness—Prednisone—rheumatoid arthritis	0.00103	0.00378	CcSEcCtD
Droxidopa—Headache—Prednisone—rheumatoid arthritis	0.00098	0.00358	CcSEcCtD
Droxidopa—Nausea—Prednisone—rheumatoid arthritis	0.000929	0.00339	CcSEcCtD
Droxidopa—Dizziness—Methotrexate—rheumatoid arthritis	0.000865	0.00316	CcSEcCtD
Droxidopa—Headache—Methotrexate—rheumatoid arthritis	0.000819	0.00299	CcSEcCtD
Droxidopa—Nausea—Methotrexate—rheumatoid arthritis	0.000777	0.00284	CcSEcCtD
Droxidopa—ADRA1A—Signaling by GPCR—CCL2—rheumatoid arthritis	8.04e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6R—rheumatoid arthritis	8.01e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL10—rheumatoid arthritis	8.01e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.01e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTK2—rheumatoid arthritis	7.92e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPP1—rheumatoid arthritis	7.89e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL5—rheumatoid arthritis	7.89e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7.88e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.86e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.85e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	7.83e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL8—rheumatoid arthritis	7.82e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPP1—rheumatoid arthritis	7.82e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.78e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—rheumatoid arthritis	7.77e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CSF2—rheumatoid arthritis	7.77e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL5—rheumatoid arthritis	7.76e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPP1—rheumatoid arthritis	7.72e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.68e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.68e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR5—rheumatoid arthritis	7.68e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	7.67e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LEP—rheumatoid arthritis	7.66e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—rheumatoid arthritis	7.65e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CSF2—rheumatoid arthritis	7.64e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	7.63e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR5—rheumatoid arthritis	7.61e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2RA—rheumatoid arthritis	7.56e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	7.55e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—rheumatoid arthritis	7.53e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR5—rheumatoid arthritis	7.51e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—rheumatoid arthritis	7.51e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—C3—rheumatoid arthritis	7.5e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2RA—rheumatoid arthritis	7.5e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—rheumatoid arthritis	7.47e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	7.47e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	7.45e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	7.44e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—rheumatoid arthritis	7.44e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—rheumatoid arthritis	7.43e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—C3—rheumatoid arthritis	7.43e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2RA—rheumatoid arthritis	7.4e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—rheumatoid arthritis	7.34e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—C3—rheumatoid arthritis	7.34e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	7.3e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPP1—rheumatoid arthritis	7.3e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	7.3e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.27e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FN1—rheumatoid arthritis	7.23e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6ST—rheumatoid arthritis	7.2e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPP1—rheumatoid arthritis	7.19e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.16e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR5—rheumatoid arthritis	7.1e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—rheumatoid arthritis	7.07e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	7.03e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2RA—rheumatoid arthritis	7e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NFKB1—rheumatoid arthritis	7e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR5—rheumatoid arthritis	6.99e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEP—rheumatoid arthritis	6.98e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—rheumatoid arthritis	6.95e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—C3—rheumatoid arthritis	6.94e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CD80—rheumatoid arthritis	6.93e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEP—rheumatoid arthritis	6.92e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	6.89e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2RA—rheumatoid arthritis	6.89e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MAPK8—rheumatoid arthritis	6.88e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—rheumatoid arthritis	6.84e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—C3—rheumatoid arthritis	6.83e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEP—rheumatoid arthritis	6.83e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	6.79e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	6.79e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	6.78e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	6.74e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	6.69e-05	0.0001	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—POMC—rheumatoid arthritis	6.64e-05	9.95e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FN1—rheumatoid arthritis	6.59e-05	9.87e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—POMC—rheumatoid arthritis	6.58e-05	9.86e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6ST—rheumatoid arthritis	6.56e-05	9.83e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	6.53e-05	9.79e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	6.52e-05	9.78e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.5e-05	9.74e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	6.5e-05	9.74e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEP—rheumatoid arthritis	6.46e-05	9.68e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—rheumatoid arthritis	6.44e-05	9.65e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FN1—rheumatoid arthritis	6.44e-05	9.65e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6R—rheumatoid arthritis	6.42e-05	9.62e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6ST—rheumatoid arthritis	6.42e-05	9.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	6.4e-05	9.6e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	6.38e-05	9.57e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEP—rheumatoid arthritis	6.36e-05	9.53e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.36e-05	9.52e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VEGFA—rheumatoid arthritis	6.35e-05	9.51e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	6.31e-05	9.46e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CD80—rheumatoid arthritis	6.31e-05	9.46e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	6.31e-05	9.45e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	6.26e-05	9.37e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	6.21e-05	9.31e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	6.21e-05	9.31e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CD80—rheumatoid arthritis	6.18e-05	9.25e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	6.12e-05	9.17e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	6.09e-05	9.13e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	6.07e-05	9.1e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	6.07e-05	9.1e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	6.07e-05	9.09e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—rheumatoid arthritis	6.05e-05	9.07e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—POMC—rheumatoid arthritis	6e-05	8.99e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FN1—rheumatoid arthritis	6e-05	8.99e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6ST—rheumatoid arthritis	5.97e-05	8.95e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	5.94e-05	8.91e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	5.93e-05	8.89e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.91e-05	8.85e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—rheumatoid arthritis	5.87e-05	8.79e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—POMC—rheumatoid arthritis	5.87e-05	8.79e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6R—rheumatoid arthritis	5.85e-05	8.77e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TYK2—rheumatoid arthritis	5.85e-05	8.76e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	5.84e-05	8.76e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—rheumatoid arthritis	5.83e-05	8.73e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	5.82e-05	8.71e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	5.8e-05	8.69e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	5.79e-05	8.68e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	5.77e-05	8.65e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CD80—rheumatoid arthritis	5.75e-05	8.62e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—rheumatoid arthritis	5.74e-05	8.6e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOS3—rheumatoid arthritis	5.74e-05	8.6e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6R—rheumatoid arthritis	5.72e-05	8.58e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.69e-05	8.52e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	5.65e-05	8.47e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	5.64e-05	8.46e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	5.64e-05	8.45e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	5.55e-05	8.32e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—rheumatoid arthritis	5.46e-05	8.19e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	5.43e-05	8.14e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	5.42e-05	8.12e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—rheumatoid arthritis	5.39e-05	8.08e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—rheumatoid arthritis	5.35e-05	8.01e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6R—rheumatoid arthritis	5.33e-05	7.99e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TYK2—rheumatoid arthritis	5.33e-05	7.99e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	5.33e-05	7.98e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.31e-05	7.95e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	5.3e-05	7.94e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	5.28e-05	7.91e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	5.25e-05	7.87e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—rheumatoid arthritis	5.23e-05	7.84e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TYK2—rheumatoid arthritis	5.21e-05	7.81e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	5.18e-05	7.77e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—rheumatoid arthritis	5.12e-05	7.67e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	5.11e-05	7.65e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—rheumatoid arthritis	5.09e-05	7.63e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	4.95e-05	7.42e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	4.93e-05	7.39e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.93e-05	7.39e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—rheumatoid arthritis	4.92e-05	7.37e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—rheumatoid arthritis	4.87e-05	7.29e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	4.85e-05	7.27e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	4.85e-05	7.27e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—rheumatoid arthritis	4.84e-05	7.26e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	4.84e-05	7.25e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—rheumatoid arthritis	4.8e-05	7.19e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	4.77e-05	7.14e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	4.75e-05	7.12e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	4.75e-05	7.11e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	4.73e-05	7.09e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	4.7e-05	7.05e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.64e-05	6.95e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—rheumatoid arthritis	4.61e-05	6.9e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.6e-05	6.89e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKB1—rheumatoid arthritis	4.56e-05	6.83e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—rheumatoid arthritis	4.54e-05	6.8e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	4.51e-05	6.76e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAPK8—rheumatoid arthritis	4.48e-05	6.71e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	4.43e-05	6.64e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	4.41e-05	6.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	4.41e-05	6.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	4.4e-05	6.59e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	4.39e-05	6.58e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—rheumatoid arthritis	4.39e-05	6.58e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	4.37e-05	6.55e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—rheumatoid arthritis	4.34e-05	6.5e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—rheumatoid arthritis	4.32e-05	6.47e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	4.31e-05	6.46e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	4.3e-05	6.45e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	4.29e-05	6.44e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	4.23e-05	6.34e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.23e-05	6.33e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	4.2e-05	6.29e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	4.16e-05	6.23e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.15e-05	6.22e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—rheumatoid arthritis	4.14e-05	6.2e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.11e-05	6.17e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—rheumatoid arthritis	4.11e-05	6.15e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	4.1e-05	6.15e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	4.08e-05	6.12e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.08e-05	6.12e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKB1—rheumatoid arthritis	4.06e-05	6.09e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.04e-05	6.06e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	4.04e-05	6.05e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	4.02e-05	6.02e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	4.01e-05	6e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.99e-05	5.98e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	3.93e-05	5.89e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	3.88e-05	5.82e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	3.84e-05	5.76e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	3.82e-05	5.73e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—rheumatoid arthritis	3.8e-05	5.69e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	3.78e-05	5.67e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	3.78e-05	5.66e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.77e-05	5.65e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.75e-05	5.63e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.73e-05	5.6e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	3.72e-05	5.57e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—rheumatoid arthritis	3.69e-05	5.52e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	3.59e-05	5.38e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	3.57e-05	5.35e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.49e-05	5.23e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	3.49e-05	5.23e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.46e-05	5.18e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.43e-05	5.14e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.43e-05	5.14e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.4e-05	5.09e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.38e-05	5.07e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.36e-05	5.03e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.33e-05	5e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.32e-05	4.97e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.3e-05	4.95e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	3.2e-05	4.8e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	3.16e-05	4.73e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.15e-05	4.72e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—rheumatoid arthritis	3.13e-05	4.68e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.12e-05	4.68e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.07e-05	4.6e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.05e-05	4.57e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—rheumatoid arthritis	2.86e-05	4.29e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	2.85e-05	4.27e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.83e-05	4.25e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	2.82e-05	4.23e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.8e-05	4.19e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—rheumatoid arthritis	2.79e-05	4.17e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	2.64e-05	3.95e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	2.61e-05	3.91e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.6e-05	3.9e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	2.59e-05	3.89e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	2.58e-05	3.87e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—rheumatoid arthritis	2.55e-05	3.82e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	2.41e-05	3.61e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	2.37e-05	3.56e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	2.3e-05	3.45e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	2.14e-05	3.21e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	2.11e-05	3.16e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.96e-05	2.94e-05	CbGpPWpGaD
